Notably, expression of Core+1/ARFP seems to relate to decreased IFNα production by peripheral blood mononuclear cells (PBMC) in hepatitis C patients [32], while it attenuates type I and type III IFN responses to RIG-I/MDA5 PAMPs in Huh7 cells [33]. This evidence concerns the gene IFNA1 and hepatitis C virus infection.